Bank of Montreal
CBIO

Bank of Montreal’s Crescent Biopharma CBIO Stock Holding History

Bank of Montreal’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11
Closed -$3K – 4161
2021
Q1 		$3K Sell
11
-47
-81% -$16.8K ﹤0.01% 4817
2020
Q4 		$22K Buy
58
+41
+241% +$14.4K ﹤0.01% 4377
2020
Q3 		$6K Sell
17
-9
-35% -$3.44K ﹤0.01% 4344
2020
Q2 		$10K Buy
+26
New +$7.36K ﹤0.01% 4166
2020
Q1 		– Sell
-74
Closed -$39K – 4318
2019
Q4 		$39K Buy
74
+44
+147% +$23.8K ﹤0.01% 3968
2019
Q3 		$13K Buy
30
+2
+7% +$1.29K ﹤0.01% 4316
2019
Q2 		$33K Buy
+28
New +$33.5K ﹤0.01% 3886
2019
Q1 		– Sell
-5
Closed -$5.72K – 4488
2018
Q4 		$5K Buy
5
+3
+150% +$3.61K ﹤0.01% 4085
2018
Q3 		$3K Sell
2
-50
-96% -$75.6K ﹤0.01% 4233
2018
Q2 		$85K Sell
52
-48
-48% -$82.5K ﹤0.01% 3203
2018
Q1 		$162K Buy
+100
New +$208K ﹤0.01% 2733
2017
Q3 		– Sell
-1
Closed -$1K – 4223
2017
Q2 		$1K Buy
+1
New +$826 ﹤0.01% 4077
2014
Q3 		– Sell
-2
Closed -$2K – 4166
2014
Q2 		$2K Buy
+2
New +$1.99K ﹤0.01% 4490

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's CBIO Position: Q2 2021 in Review

Bank of Montreal sold out of Crescent Biopharma (CBIO) in Q2 2021, closing a stake of 11 shares — an estimated $3K sold.

Bank of Montreal first reported a position in CBIO in Q2 2014 and held it in 13 quarters. The position peaked at $162K in Q1 2018. 58 funds tracked by Wall St. Rank hold CBIO as of Q2 2021.

  • Bank of Montreal reported no remaining Crescent Biopharma position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 11 Crescent Biopharma shares in Q2 2021, an estimated $3K.
  • Bank of Montreal first reported a position in Crescent Biopharma in Q2 2014 and held it in 13 quarters.
  • Bank of Montreal's Crescent Biopharma position peaked at $162K in Q1 2018.
  • 58 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.